EBS

EBS Total Assets

$1.12BQuarterly · USD

Period ending:

EBS FY Total AssetsUSD
EBS FY Total Assets2001-12-31: $25.42M2002-12-31: $22.79M2004-12-31: $69.06M2005-12-31: $100.33M2006-12-31: $238.26M2007-12-31: $273.51M2008-12-31: $290.79M2009-12-31: $344.69M2010-12-31: $500.32M2011-12-31: $546.86M2012-12-31: $564.23M2013-12-31: $626.63M2014-12-31: $945.26M2015-12-31: $1.04B2016-12-31: $970.11M2017-12-31: $1.07B2018-12-31: $2.23B2019-12-31: $2.33B2020-12-31: $2.88B2021-12-31: $2.96B2022-12-31: $3.17B2023-12-31: $1.82B2024-12-31: $1.39B2025-12-31: $1.32B$3.17B$0.00
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

EBS total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 24 observations from Dec 31, 2001 to Dec 31, 2025.

Emergent Biosolutions Inc Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
1,318,600,000
1,389,700,000
1,823,200,000
3,166,300,000
2,957,700,000
2,883,200,000
2,327,300,000
2,229,400,000
1,070,206,000
970,111,000
1,043,592,000
945,262,000
626,630,000
564,230,000
546,864,000
500,319,000
344,689,000
290,788,000
273,508,000
238,255,000
100,332,000
69,056,000
22,790,000
25,423,000

Compare total assets

All EBS financial metrics · EBS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.